Physician
TBHC Medical Services, PC
TBHC Medical Services, PC was paid $7.41M by Medicaid between Jan 2018 and Dec 2024, across 99 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 41% of everything it billed.
33Billing provider infoTBHC MEDICAL SERVICES, PC
BROOKLYN, NY 11201
BROOKLYN, NY 11201
33aNPI1508959743assigned 10/02/2006
33bProvider typeCardiovascular Disease Physician
28Total paid$7.41M
24GClaims336,350
24DCodes billed99
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Cardiovascular Disease Physician providers in New York
Rank by total paid#7 of 1,564
Median peer was paid$13K
This provider vs. median570×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24,350 | $930K | |
| 2019 | 34,761 | $1.09M | |
| 2020 | 25,699 | $967K | |
| 2021 | 74,800 | $1.57M | |
| 2022 | 67,503 | $1.13M | |
| 2023 | 66,115 | $1.02M | |
| 2024incomplete | 43,122 | $706K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 41% | 53,964 | 50,716 | $3.07M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 21,893 | 21,319 | $1.76M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 9.1% | 6,709 | 6,640 | $674K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 3.8% | 5,369 | 3,105 | $279K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 3.0% | 674 | 674 | $223K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2.5% | 31,538 | 26,217 | $189K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 2.0% | 1,630 | 1,628 | $149K |
| 99222 | Initial hospital care, per day, moderate complexity | 1.6% | 1,217 | 1,185 | $122K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.6% | 3,808 | 3,644 | $117K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.4% | 749 | 748 | $104K |
| 93015 | 1.2% | 1,547 | 1,544 | $92K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.2% | 1,166 | 930 | $88K |
87 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.2% | 2,560 | $87K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 827 | $72K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 640 | $71K |
| 99442 | <1% | 1,214 | $55K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 601 | $46K |
| 99223 | Prolong inpt eval add15 m | <1% | 203 | $32K |
| 93000 | <1% | 2,619 | $32K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,968 | $26K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 138 | $13K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 843 | $12K |
| 93454 | <1% | 69 | $11K | |
| 90686 | <1% | 684 | $11K | |
| A9505 | Thallium tl-201 thallous chloride, diagnostic, per millicurie | <1% | 230 | $10K |
| 99441 | <1% | 488 | $8K | |
| 99307 | <1% | 221 | $8K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 162 | $8K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 121 | $7K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 123 | $7K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 50 | $5K |
| 99236 | Prolong inpt eval add15 m | <1% | 17 | $4K |
| 93458 | <1% | 12 | $3K | |
| 97802 | <1% | 37 | $3K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 39 | $2K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 239 | $2K |
| 99385 | <1% | 12 | $2K | |
| 97803 | <1% | 26 | $1K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 53 | $1K |
| 93016 | <1% | 53 | $1K | |
| 90673 | <1% | 16 | $888.97 | |
| 99201 | <1% | 17 | $734.27 | |
| 99443 | <1% | 20 | $727.84 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 15 | $667.71 |
| 93018 | <1% | 51 | $660.67 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 17 | $418.03 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 22 | $370.49 |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | <1% | 41 | $348.36 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 26 | $301.90 |
| 99406 | <1% | 24 | $271.10 | |
| 3074F | <1% | 19,367 | $142.78 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 202 | $136.85 |
| 3078F | <1% | 17,529 | $126.64 | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 12 | $31.16 |
| 1160F | <1% | 4,669 | $18.06 | |
| G0008 | Administration of influenza virus vaccine | <1% | 28 | $16.00 |
| 1159F | <1% | 4,788 | $10.21 | |
| 3075F | <1% | 2,814 | $9.84 | |
| 1126F | <1% | 3,033 | $8.08 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | <1% | 31,264 | $5.91 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 35,744 | $5.91 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | <1% | 5,371 | $2.66 |
| 3044F | <1% | 15,295 | $2.34 | |
| 1170F | <1% | 2,349 | $2.34 | |
| G9899 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed | <1% | 250 | $0.45 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 75 | $0.14 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | <1% | 125 | $0.14 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 1,510 | $0.00 |
| 3077F | 0% | 2,411 | $0.00 | |
| G8506 | Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy | 0% | 7,934 | $0.00 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 3,650 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 689 | $0.00 |
| G8540 | Functional outcome assessment not documented as being performed, documentation the patient is not eligible for a functional outcome assessment using a standardized tool at the time of the encounter | 0% | 162 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 72 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 259 | $0.00 |
| G8731 | Pain assessment using a standardized tool is documented as negative, no follow-up plan required | 0% | 263 | $0.00 |
| 4004F | 0% | 85 | $0.00 | |
| 1124F | 0% | 118 | $0.00 | |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 76 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 14 | $0.00 |
| 2022F | 0% | 29 | $0.00 | |
| 4040F | 0% | 49 | $0.00 | |
| 3725F | 0% | 19 | $0.00 | |
| 3045F | 0% | 16 | $0.00 | |
| 4010F | 0% | 7,812 | $0.00 | |
| 1036F | 0% | 8,098 | $0.00 | |
| 1125F | 0% | 711 | $0.00 | |
| 3061F | 0% | 2,747 | $0.00 | |
| G9664 | Patients who are currently statin therapy users or received an order (prescription) for statin therapy | 0% | 446 | $0.00 |
| 3079F | 0% | 8,770 | $0.00 | |
| 3066F | 0% | 1,500 | $0.00 | |
| 1123F | 0% | 426 | $0.00 | |
| 3060F | 0% | 277 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 30 | $0.00 |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 98 | $0.00 |
| 3017F | 0% | 223 | $0.00 | |
| 3080F | 0% | 63 | $0.00 | |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 103 | $0.00 |
| G8542 | Functional outcome assessment using a standardized tool is documented; no functional deficiencies identified, care plan not required | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAMIRFAR, SAM (OWNER, AUTHORIZED SIGNATORY)